6-APDB

Description

6-APDB (also known as 6-(2-aminopropyl)-2,3-dihydro benzofuran or 4-Desoxy-MDA) is a stimulant and entactogenic research chemical of the phenethylamine and benzofuran classes.5-apdb,6-apb source,5-apb legal status USA,2-aminopropyl benzofuran

It is a closely related synthetic analogue of MDA and 6-APB and broadly shares the characteristics of serotonin-selective triple monoamine releasers and reuptake inhibitors associated with other entactogenic or empathogenic compounds.

6-APDB was first synthesized and studied along with 5-APDB in 1993 by David E. Nichols as a potential non-neurotoxic alternative to MDMA.

It did not come into popular recreational use until over a decade later, where it briefly entered the rave scene and global research chemicals market, in particular the “legal highs” market in the U.K., before its sale and import were subsequently banned.5-apdb,6-apb source,5-apb legal status USA,2-aminopropyl benzofuran

Because 6-APDB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity as a substitute or replacement for serotonergic entactogens like MDMA or MDA, and are typically distributed through the online research chemicals grey market.

6-APDB, also known as 6-(2-aminopropyl)-2,3-dihydro benzofuran, is a synthetic molecule of the benzofuran family. Molecules of this class contain a phenethylamine core bound to an amino (NH₂) group through an ethyl chain with an additional methyl substitution at R_?.

6-APDB does not contain a methyl substitution on R_N, a motif which it shares with MDA. It is an analogue of MDA where the heterocyclic 4-position oxygen from the 3,4-methylenedioxy ring has been replaced with a methylene bridge. 6-APDB shares this furan ring with 5-APDB, 5-MAPDB and 6-MAPDB.